ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,291.60
0.30%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,313.71
-1.09%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Supernus Pharmaceuticals Inc (SUPN)

  7. Supernus Pharmaceuticals Inc (SUPN) 뉴스

SUPN Supernus Pharmaceuticals Inc

30.07
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Supernus Pharmaceuticals Inc SUPN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 30.07 20:00:00
개장가 저가 고가 종가 전일 종가
30.07
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202405:05GLOBESupernus Pharmaceuticals to Announce First Quarter 2024..
08/04/202421:00GLOBESupernus Provides Regulatory Update for SPN-830
07/03/202406:30GLOBESupernus to Participate in Two Upcoming Investor Conferences
01/03/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202407:00EDGAR2Form 8-K - Current report
29/02/202406:30GLOBESupernus to Participate in the TD Cowen 44th Annual..
28/02/202407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/02/202406:05GLOBESupernus Announces Fourth Quarter and Full Year 2023..
27/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:27EDGAR2Form 144 - Report of proposed sale of securities
23/02/202407:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202404:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202421:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202406:08EDGAR2Form 8-K - Current report
14/02/202406:05GLOBESupernus Pharmaceuticals to Announce Fourth Quarter and Full..
05/02/202423:21EDGAR2Form 8-K - Current report
05/02/202422:30GLOBESupernus Wins Infringement and Validity Case on Trokendi XR®..
13/01/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202406:08EDGAR2Form 144 - Report of proposed sale of securities
27/12/202307:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:30GLOBEKnight Therapeutics Enters into Exclusive License Agreement..
19/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202319:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
18/11/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202306:22EDGAR2Form 144 - Report of proposed sale of securities
15/11/202304:59EDGAR2Form 144 - Report of proposed sale of securities
09/11/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:10EDGAR2Form 8-K - Current report
09/11/202306:05GLOBESupernus Announces Third Quarter 2023 Financial Results
08/11/202306:30GLOBESupernus to Participate in the Jefferies London Healthcare..
03/11/202305:24EDGAR2Form 8-K - Current report
02/11/202320:00GLOBESupernus Announces SPN-830 Apomorphine Infusion Device NDA..
26/10/202305:19EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
SUPN
Supernus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유